MAM
Imagine TV fails to boost ratings sans Swayamvar
MUMBAI: For the second consecutive week, Imagine TV has proved that its fortunes are heavily dependent on the Swayamvar franchise.
The channel, which had crossed the 100 GRP (gross rating point) mark two weeks back with the culmination of Swayamvar season 3, Ratan ka Rishta, slumped to 65 GRPs in the immediate week after that.
Even in the week ended 23 July, the channel remained stagnant with 66 GRPs under its kitty.
After the first and second season of the Swayamvar series, Imagine TV had also seen a drastic fall in ratings.
Meanwhile, for the week ended 23 July the status quo has been maintained among the Hindi general entertainment channels. Star Plus continues to lead with 316 GRPs (last week 320) followed by Colors with 267 GRPs (last week 271), according to Tam data for the Hindi speaking markets.
Zee TV, which was witnessing a fall over the last few weeks, was the top gainer in the week. The channel saw a 35 GRP jump in the week to close with 220 GRP (from 185). Sony Entertainment Television, however, is still in pursuit and ended the week with 193 GRPs (from 182 in the last week).
Sab, meanwhile, fell to 124 GRPs from 133 in the preceding week while Star One and Sahara One were at 36 and 33 GRPs respectively.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
